Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,094 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma.
Ravaud A, Barrios CH, Alekseev B, Tay MH, Agarwala SS, Yalcin S, Lin CC, Roman L, Shkolnik M, Anak O, Gogov S, Pelov D, Louveau AL, Melichar B. Ravaud A, et al. Among authors: yalcin s. Ann Oncol. 2015 Jul;26(7):1378-84. doi: 10.1093/annonc/mdv170. Epub 2015 Apr 7. Ann Oncol. 2015. PMID: 25851632 Free article. Clinical Trial.
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.
Schultheis B, Reuter D, Ebert MP, Siveke J, Kerkhoff A, Berdel WE, Hofheinz R, Behringer DM, Schmidt WE, Goker E, De Dosso S, Kneba M, Yalcin S, Overkamp F, Schlegel F, Dommach M, Rohrberg R, Steinmetz T, Bulitta M, Strumberg D. Schultheis B, et al. Among authors: yalcin s. Ann Oncol. 2017 Oct 1;28(10):2429-2435. doi: 10.1093/annonc/mdx343. Ann Oncol. 2017. PMID: 28961832 Free article. Clinical Trial.
Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma.
Kars A, Celik I, Kansu E, Tekuzman G, Ozişik Y, Güler N, Barişta I, Güllü I, Yalçin S, Altundağ K, Zengin N, Türker A, Hayran M, Baltali E, Firat D. Kars A, et al. Among authors: yalcin s. Eur J Haematol. 1997 Aug;59(2):100-4. doi: 10.1111/j.1600-0609.1997.tb00732.x. Eur J Haematol. 1997. PMID: 9293857 Clinical Trial.
Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction.
Dank M, Zaluski J, Barone C, Valvere V, Yalcin S, Peschel C, Wenczl M, Goker E, Cisar L, Wang K, Bugat R. Dank M, et al. Among authors: yalcin s. Ann Oncol. 2008 Aug;19(8):1450-1457. doi: 10.1093/annonc/mdn166. Epub 2008 Jun 16. Ann Oncol. 2008. PMID: 18558665 Free article. Clinical Trial.
1,094 results